Share Name Share Symbol Market Type Share ISIN Share Description
Benchmark Holdings Plc LSE:BMK London Ordinary Share GB00BGHPT808 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.75 1.2% 63.25 62.50 64.00 - 34,235 16:35:21
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 105.6 -22.6 -5.3 - 424

Benchmark Share Discussion Threads

Showing 976 to 997 of 1000 messages
Chat Pages: 40  39  38  37  36  35  34  33  32  31  30  29  Older
No need for Govts to "mandate" it. If it works, the farmers will buy it. They can't afford not to.
murdo mcsponge
the reality if it works - it should be mandated - my only concern is that the likes of vietnam govt are not going to mandate this till it is too late.
i guess that would stop need for anitbiotics in feed which would not only save costs but potentially save the planet!
That's been my belief. If they have come up with either disease resistant shrimp, or a way of stimulating something akin to an immune response, I believe that would be a serious winner with a very big market. I thought that Shrimp didn't have an immune response, and I did ask Malcolm Pye about it at an AGM about 3 or 4 years ago, and he indicated that while they don't have the sort of immune system that we recognize, they do have some sort of system for fighting off infections. If BMK have something, the market should be enormous, and it's one of the main reasons BMK is the biggest holding in my Portfolio.
murdo mcsponge
Anyone know much about the disease resistant shrimp? Surely this could be a big part of the business if effective...
Investor Webinar recording now available! We hosted an investor webinar on 1st September with the management of Benchmark Holdings. Trond Williksen, CEO, and Septima Maguire, CFO gave investors an insight into the financial and operational results for the Q3 period, shared views on their outlook and took investor questions. You can watch the full recording on the link below. Total video length 26 minutes. https://www.equitydevelopment.co.uk/research/benchmark-q3results-presentation
Q3 results due tomorrow according to google finance - but i suspect it will be 7am on morning of Webinar ?
Sounds great but two bogeymen on the horizon. The first, it is quite probable that the MRL will NOT get sanctioned. Secondly, the CleanTreat system is yet to be evaluated and will not meet current validation requirements. I’d advise extreme caution.
Norway’s Medicines Agency (NoMA) has approved Benchmark Holdings’ parasiticide BMK08 (imidacloprid) - to be branded Ectosanâ Vet - for the treatment of sea lice in farmed salmon when used with its CleanTreatâ water treatment system. Norway is the largest producer of farmed salmon globally and will be the initial focus of Benchmark’s commercialisation efforts. Ectosanâ Vet can only be sold with the CleanTreatâ water purification system, which has been developed in parallel to prevent environmental contamination of the ocean. Two CleanTreatâ units are ready for the launch and up to five may be required to service the Norwegian salmon farming industry. Each CleanTreatâ unit may generate sales of c £10m/year at full utilisation, so this new technology potentially represents a major contributor to revenue and EBITDA. https://www.equitydevelopment.co.uk/research/cleared-to-launch-bmk08-/-ectosan-vet-in-norway
Our fair value per share of 88p represents a near 50% premium to the current price https://www.equitydevelopment.co.uk/research/growth-drivers-aligned-with-aquaculture-sustainability-goals
Benchmark Interim Results Presentation 18th May 2021 Trond Williksen, CEO, and Septima Maguire, CFO, run through their results, the progress they are making on the route to commercialising BMK08 and CleanTreat, and how the journey to cash flow break even is progressing. https://www.equitydevelopment.co.uk/research/benchmark-interim-results-presentation-1
Benchmark Holdings (LON:BMK) interim results presentation to analysts, 18.5.21 by Trond Willliksen, CEO, and Septima Maguire, CFO. Good H1 performance with revenue growth +11% and Adjusted EBITDA +13% reflecting a strong performance in Advanced Nutrition and solid trading in Genetics and Health. Significant progress towards commercialisation of BMK08 and Clean Treat. Positive outlook and trading in line with market expectations, with good revenue visibility for the second half. Https://www.piworld.co.uk/2021/05/19/benchmark-holdings-bmk-interim-results-presentation-to-analysts/
listened in - lets say 6 boats in 3 years with a 60% margin and £10m revenue per boat with a capex spend of £2m per boat. well - even i can work out that is transformational for the group. what else can these boats treat fish for too other than sealice is my other question...
yes but it does show that we need firms like bmk trying to improve the welfare of the fish and the health of the oceans.
Have you seen the film SEAPIRACY on Nexflex. Puts one off eating fish
hoorah on cleantreat contract. about time. lets hope the regulator can tick their box soon too. lets look forward to more of these wins and enjoy the 60% margins alluded to . they have been a while coming!
Malcolm Pye? - good luck with guys.
st augustus
25/02/2021 07:00 UK Regulatory (RNS & others) OTAQ PLC Non-Executive Director Appointment OTAQ, the marine technology products and solutions group for the global aquaculture and offshore oil and gas industries, is pleased to announce that Malcolm Pye will join the Board of OTAQ as a Non-Executive Director with immediate effect. Malcolm founded, and from 1999 to 2019 was Chief Executive of, Benchmark Holdings plc ("Benchmark"), the world's leading aquaculture health, nutrition and genetics business. Malcolm has over 35 years' experience in international agribusiness through his various roles at Hillsdown Holdings (then HMTF Group), and through building Benchmark from the initial start-up into a major international aquaculture technology business serving the global salmon, shrimp, tilapia and farmed fish industries. Malcolm focused Benchmark's activities on animal health, breeding and genetics, advanced nutrition and knowledge/technology delivery and led the flotation of Benchmark in 2013, maintaining a lead role in investor engagement. Prior to his founding role at Benchmark, Malcolm gained wide experience in the food sector from his various senior management positions within Hillsdown Holdings, operating in animal breeding, poultry production, feed milling and veterinary services. During this time, he developed extensive experience in breeding and genetics, food production/technology, sales (including account lead responsibilities within the UK / international retail sector with a range of bluechip companies including M&S, Tesco and McDonalds) and strategic M&A as well as holding a main board position within the Group. Malcolm's work with Hillsdown Holdings in the early to mid-1990's influenced a career-long focus on sustainable food production which formed the basis and inspiration for the creation of Benchmark Holdings. Alex Hambro, Non-Executive Chairman, commented: "We are really delighted to welcome Malcolm to the Board of OTAQ. Malcolm's experience in, and knowledge of, the global aquaculture industry is unparalleled, and will be of huge benefit to OTAQ as it develops and commercialises additional sustainable technologies and services for the aquaculture farming and producing communities. Our core SealFence acoustic deterrence system has significant opportunities for growth in geographies where Malcolm has built strong long-term relationships. Furthermore, his knowledge of additional farmed species other than salmon will be extremely helpful as we expand our range of products ." Aside from the information set out in the announcement above, no further information is required to be disclosed pursuant to Listing Rule 9.6.13R. https://uk.advfn.com/stock-market/london/otaq-OTAQ/share-news/OTAQ-PLC-Non-Executive-Director-Appointment/84427020
hedgehog 100
ED raised their target from 72 to 88p www.equitydevelopment.co.uk/research/well-set-ahead-of-key-product-launches
Nice end to the yr!
Benchmark (BMK) FY20 analyst presentation Trond Williksen, CEO & Spetima Maguire, CFO present FY20 results to analysts. Video: Https://www.piworld.co.uk/2020/12/14/benchmark-bmk-fy20-results-analyst-presentation/ Podcast: Https://www.piworld.co.uk/podcasts/
Benchmark Holdings plc transformed operations during FY20 against the challenging macro conditions brought about by Covid-19, completing a fundamental restructuring via nine disposals in a 12-month period. The latter raising up to £44m, with the closure of non-core or loss-making activities allowing a refocus of the business on aquaculture and a rebasing of the cost structure. Consequently, BMK has reinforced its financial position, boosted liquidity by £50m, and appears very well positioned to execute its growth strategy to achieve commercial returns. This leads us to upgrade our FY 21/22 AEBITDA forecasts and to expect a net profit in FY23. The Group is uniquely positioned to build selectively on its leading market positions in aquaculture, notably in developing innovative and sustainable products, diversifying its product range, coupled with a strong focus on profitability and from a position of improved balance sheet strength. We also raise our retained value per share from 63p to 72p on our updated forecasts. While the shares have performed well on the back of successful disposals, those gains look fully justified. https://www.equitydevelopment.co.uk/research/progress-on-the-road-to-profitability
Chat Pages: 40  39  38  37  36  35  34  33  32  31  30  29  Older
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210925 11:02:53